A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Mar 18, 2012
0
0
The tiny mouse embryo has a heart that beats. Its muscles, blood vessels, gut and nervous system are beginning to develop. But this embryo is unusual: It was made in a lab, out of mouse embryonic stem cells, and represents ...
Jun 29, 2021
0
27
(Medical Xpress) -- Scientists at The University of Nottingham are developing microscopic organic medical imaging systems to support a new generation of breakthrough treatments for currently incurable diseases and chronic ...
Oct 5, 2011
0
0
(Medical Xpress)—Researchers from King's College London's Institute of Psychiatry (IoP) have identified new biomarkers for antidepressant treatment response, an important step towards developing personalised treatments ...
Sep 20, 2012
0
0
An analysis on the positive effects of exercise on blood sugar levels in people with type 2 diabetes shows that while all exercise helps, certain activities—and their timing—are extremely good for people's health.
Jun 28, 2023
0
12
Liver cancer's rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at ...
Aug 2, 2022
0
72
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Oct 1, 2012
0
0
Microscale needle-electrode array technology has enhanced brain science and engineering applications, such as electrophysiological studies, drug and chemical delivery systems, and optogenetics.
Aug 10, 2015
0
19
ETC-159, an anti-cancer drug that is currently in early phase clinical trials for use in a subset of colorectal and gynecological cancers, could also prevent some tumors from resisting therapies by blocking a key DNA repair ...
Mar 16, 2021
0
59
Disease-free survival is short-lived for women with triple-negative breast cancer—a form of the disease that doesn't respond to hormone drugs and becomes resistant to chemotherapy. Thankfully, a promising line of study ...
Oct 2, 2012
0
0
